Selecta Biosciences Return on Equity

Selecta Biosciences (SELB) currently reports a ROE of 121.29%. That is above the Healthcare sector average of 21.67%. Use the charts on this page to explore Selecta Biosciences's ROE history and peer comparisons.

Selecta Biosciences's ROE of 121.29% is higher than the Healthcare sector average of 21.67%. That is roughly 459.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Selecta Biosciences's current 121.29% should be judged against Healthcare norms (sector average: 21.67%) and against SELB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 121.29%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Selecta Biosciences, and consider following SELB for alerts when major investors trade the stock.

Selecta Biosciences is classified in the Healthcare sector. On ROE, it currently shows 121.29% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SELB with unrelated industries.